{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T10:49:39Z","timestamp":1792838979937,"version":"4.5.0"},"reference-count":156,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T00:00:00Z","timestamp":1682985600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018559","name":"Shenyang Young and Middle-aged Science and Technology Innovation Talent Support Program","doi-asserted-by":"publisher","award":["RC210011"],"award-info":[{"award-number":["RC210011"]}],"id":[{"id":"10.13039\/501100018559","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.jhepr.2023.100785","type":"journal-article","created":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T22:47:29Z","timestamp":1683240449000},"page":"100785","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Use of albumin infusion for cirrhosis-related complications: An international position statement"],"prefix":"10.1016","volume":"5","author":[{"given":"Zhaohui","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahum","family":"M\u00e9ndez-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9394-6895","authenticated-orcid":false,"given":"Fernando Gomes","family":"Romeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Mancuso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9587-336X","authenticated-orcid":false,"given":"Cyriac Abby","family":"Philips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6206-0226","authenticated-orcid":false,"given":"Frank","family":"Tacke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8500-1333","authenticated-orcid":false,"given":"Metin","family":"Basaranoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Primignani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6019-5055","authenticated-orcid":false,"given":"Mostafa","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0727-1183","authenticated-orcid":false,"given":"Yu Jun","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6644-2985","authenticated-orcid":false,"given":"Filipe Gaio","family":"Nery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8910-1200","authenticated-orcid":false,"given":"Rolf","family":"Teschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Noronha","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto E.","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5231-7582","authenticated-orcid":false,"given":"Kanokwan","family":"Pinyopornpanish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3974-2784","authenticated-orcid":false,"given":"Thierry","family":"Thevenot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivaram Prasad","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8408-8075","authenticated-orcid":false,"given":"Arpan","family":"Mohanty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0153-2829","authenticated-orcid":false,"given":"Sanjaya K.","family":"Satapathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8596-2609","authenticated-orcid":false,"given":"Lorenzo","family":"Ridola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3371-3157","authenticated-orcid":false,"given":"Hitoshi","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos","family":"Cholongitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7893-5047","authenticated-orcid":false,"given":"Giovanni Battista","family":"Levi Sandri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Shalimar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8307-1095","authenticated-orcid":false,"given":"Yongping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6388-7022","authenticated-orcid":false,"given":"Erica","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9598-4932","authenticated-orcid":false,"given":"Aleksander","family":"Krag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9263-8869","authenticated-orcid":false,"given":"Florence","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7747-4015","authenticated-orcid":false,"given":"Rajiv","family":"Jalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1308-5440","authenticated-orcid":false,"given":"Mauro","family":"Bernardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9448-6739","authenticated-orcid":false,"given":"Xingshun","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2023.100785_bib1","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","article-title":"Liver cirrhosis","volume":"398","author":"Gin\u00e8s","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jhepr.2023.100785_bib2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100785_bib3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S2468-1253(19)30349-8","article-title":"The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"5","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100785_bib4","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1056\/NEJMra1504367","article-title":"Treatment of patients with cirrhosis","volume":"375","author":"Ge","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhepr.2023.100785_bib5","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jhep.2014.04.012","article-title":"Human serum albumin, systemic inflammation, and cirrhosis","volume":"61","author":"Arroyo","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100785_bib6","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100785_bib7","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1016\/j.jhep.2021.01.024","article-title":"The search for disease-modifying agents in decompensated cirrhosis: from drug repurposing to drug discovery","volume":"75","author":"Caraceni","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100785_bib8","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/s41575-018-0045-2","article-title":"Novel perspectives in the management of decompensated cirrhosis","volume":"15","author":"Bernardi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100785_bib9","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/S0140-6736(18)30840-7","article-title":"Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial","volume":"391","author":"Caraceni","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jhepr.2023.100785_bib10","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.jhep.2018.08.006","article-title":"Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial","volume":"69","author":"Sol\u00e0","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100785_bib11","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa2022166","article-title":"A randomized trial of albumin infusions in hospitalized patients with cirrhosis","volume":"384","author":"China","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhepr.2023.100785_bib12","doi-asserted-by":"crossref","DOI":"10.1177\/1756284819881302","article-title":"Association of serum albumin level with incidence and mortality of overt hepatic encephalopathy in cirrhosis during hospitalization","volume":"12","author":"Bai","year":"2019","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100785_bib13","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1478-3231.2010.02377.x","article-title":"Recurrence of spontaneous bacterial peritonitis in cirrhotic patients non-prophylactically treated with norfloxacin: serum albumin as an easy but reliable predictive factor","volume":"31","author":"Huang","year":"2011","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2023.100785_bib14","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1007\/s12072-022-10374-z","article-title":"Use of human albumin infusion in cirrhotic patients: a systematic review and meta-analysis of randomized controlled trials","volume":"16","author":"Bai","year":"2022","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhepr.2023.100785_bib15","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/hep.31884","article-title":"Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the American association for the study of liver diseases","volume":"74","author":"Biggins","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100785_bib16","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1345\/aph.19385","article-title":"Costs related to inappropriate use of albumin in Spain","volume":"34","author":"Tar\u00edn Remoh\u00ed","year":"2000","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jhepr.2023.100785_bib17","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/ajhp\/60.13.1330","article-title":"Evaluation of the appropriate use of albumin in adult and pediatric patients","volume":"60","author":"Tanzi","year":"2003","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jhepr.2023.100785_bib18","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/tme.12406","article-title":"Where does the Albumin go? Human Albumin Solution usage following the implementation of a demand management programme","volume":"27","author":"Yazdani","year":"2017","journal-title":"Transfus Med"},{"key":"10.1016\/j.jhepr.2023.100785_bib19","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/MCG.0000000000000735","article-title":"Albumin use in patients with cirrhosis in France: results of the \u201cALBU-LIVE\u201d survey: a case for better EASL guidelines diffusion and\/or revision","volume":"51","author":"Garioud","year":"2017","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100785_bib20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/jcag\/gwaa027","article-title":"Intravenous albumin in patients with cirrhosis: evaluation of practice patterns and secular trends of usage in ontario 2000 to 2017","volume":"4","author":"Rodrigues","year":"2021","journal-title":"J Can Assoc Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100785_bib21","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1002\/hep.27789","article-title":"Variations in albumin use in patients with cirrhosis: an AASLD members survey","volume":"62","author":"Bajaj","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100785_bib22","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1080\/17474124.2018.1460203","article-title":"The use of human albumin in patients with cirrhosis: a European survey","volume":"12","author":"Caraceni","year":"2018","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100785_bib23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/gutjnl-2020-321790","article-title":"Guidelines on the management of ascites in cirrhosis","volume":"70","author":"Aithal","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2023.100785_bib24","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1002\/hep.22853","article-title":"Management of adult patients with ascites due to cirrhosis: an update","volume":"49","author":"Runyon","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100785_bib25","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/gutjnl-2014-308874","article-title":"Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites","volume":"64","author":"Angeli","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2023.100785_bib26","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.dld.2015.11.008","article-title":"AISF-SIMTI Position Paper: the appropriate use of albumin in patients with liver cirrhosis","volume":"48","year":"2016","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhepr.2023.100785_bib27","first-page":"9","article-title":"AISF-SIMTI position paper on the appropriate use of albumin in patients with liver cirrhosis: a 2020 update","volume":"19","author":"Caraceni","year":"2021","journal-title":"Blood Transfus"},{"key":"10.1016\/j.jhepr.2023.100785_bib28","doi-asserted-by":"crossref","first-page":"100708","DOI":"10.1016\/j.aohep.2022.100708","article-title":"Position statement on the use of albumin in liver cirrhosis","author":"Castro-Narro","year":"2022","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jhepr.2023.100785_bib29","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.jpainsymman.2013.01.014","article-title":"Consensus building on access to controlled medicines: a four-stage Delphi consensus procedure","volume":"46","author":"J\u00fcnger","year":"2013","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jhepr.2023.100785_bib30","first-page":"458","article-title":"An experimental application of the DELPHI method to the use of experts","volume":"9","author":"Helmer","year":"1963","journal-title":"Manag Sci"},{"key":"10.1016\/j.jhepr.2023.100785_bib31","doi-asserted-by":"crossref","first-page":"i1152","DOI":"10.1136\/bmj.i1152","article-title":"Agree Next Steps Consortium. The AGREE Reporting Checklist: a tool to improve reporting of clinical practice guidelines","volume":"352","author":"Brouwers","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jhepr.2023.100785_bib32","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1089\/jpm.2018.0553","article-title":"Attitudes of liver and palliative care clinicians toward specialist palliative care consultation for patients with end-stage liver disease","volume":"22","author":"Esteban","year":"2019","journal-title":"J Palliat Med"},{"key":"10.1016\/j.jhepr.2023.100785_bib33","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jhepr.2023.100785_bib34","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2147\/IJGM.S102819","article-title":"Human serum albumin homeostasis: a new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurements","volume":"9","author":"Levitt","year":"2016","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.jhepr.2023.100785_bib35","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/hep.20720","article-title":"Albumin: biochemical properties and therapeutic potential","volume":"41","author":"Quinlan","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100785_bib36","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1248\/bpb.25.695","article-title":"Practical aspects of the ligand-binding and enzymatic properties of human serum albumin","volume":"25","author":"Kragh-Hansen","year":"2002","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.jhepr.2023.100785_bib37","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/S0531-5565(02)00175-4","article-title":"Aging-related changes in the thiol\/disulfide redox state: implications for the use of thiol antioxidants","volume":"37","author":"Dr\u00f6ge","year":"2002","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.jhepr.2023.100785_bib38","series-title":"Physiology, albumin","author":"Moman","year":"2021"},{"key":"10.1016\/j.jhepr.2023.100785_bib39","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.1016\/j.bbagen.2013.04.023","article-title":"Albumin as a versatile platform for drug half-life extension","volume":"1830","author":"Sleep","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jhepr.2023.100785_bib40","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s42003-020-0903-7","article-title":"An intact C-terminal end of albumin is required for its long half-life in humans","volume":"3","author":"Nilsen","year":"2020","journal-title":"Commun Biol"},{"key":"10.1016\/j.jhepr.2023.100785_bib41","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1172\/JCI105694","article-title":"Use of 125-I- and 51-Cr-labeled albumin for the measurement of gastrointestinal and total albumin catabolism","volume":"46","author":"Kerr","year":"1967","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhepr.2023.100785_bib42","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/hep.26321","article-title":"Deficiency of intestinal mucin-2 ameliorates experimental alcoholic liver disease in mice","volume":"58","author":"Hartmann","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100785_bib43","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.26338","article-title":"Albumin: pathophysiologic basis of its role in the treatment of cirrhosis and its complications","volume":"58","author":"Garcia-Martinez","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100785_bib44","doi-asserted-by":"crossref","first-page":"547","DOI":"10.5604\/01.3001.0012.0916","article-title":"New insights about albumin and liver disease","volume":"17","author":"Carvalho","year":"2018","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jhepr.2023.100785_bib45","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1002\/hep.31798","article-title":"Determination of effective albumin in patients with decompensated cirrhosis: clinical and prognostic implications","volume":"74","author":"Baldassarre","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100785_bib46","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.3109\/00365521.2012.696682","article-title":"In-111 transferrin scintigraphy in cirrhosis with hypoalbuminemia: evidence for protein-losing enteropathy in a small group of selected cases","volume":"47","author":"Dahlqvist","year":"2012","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100785_bib47","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000196916","article-title":"Protein-losing enteropathy in patients with liver cirrhosis","volume":"2","author":"Davcev","year":"1969","journal-title":"Digestion"},{"key":"10.1016\/j.jhepr.2023.100785_bib48","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.jhep.2013.08.001","article-title":"Effective albumin concentration and cirrhosis mortality: from concept to reality","volume":"59","author":"Jalan","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100785_bib49","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/j.febslet.2008.04.057","article-title":"The antioxidant properties of serum albumin","volume":"582","author":"Roche","year":"2008","journal-title":"FEBS Lett"},{"issue":"Suppl 1","key":"10.1016\/j.jhepr.2023.100785_bib50","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.jhep.2021.01.002","article-title":"Pathophysiology of decompensated cirrhosis: portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction","volume":"75","author":"Engelmann","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100785_bib51","series-title":"Prerenal kidney failure","author":"Manzoor","year":"2022"},{"key":"10.1016\/j.jhepr.2023.100785_bib52","first-page":"1310","article-title":"Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis","volume":"56","author":"Salerno","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2023.100785_bib53","first-page":"164","article-title":"Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis","volume":"23","author":"Arroyo","year":"1996","journal-title":"International Ascites Club. Hepatology"},{"key":"10.1016\/j.jhepr.2023.100785_bib54","doi-asserted-by":"crossref","first-page":"m2687","DOI":"10.1136\/bmj.m2687","article-title":"Hepatorenal syndrome: pathophysiology, diagnosis, and management","volume":"370","author":"Simonetto","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.jhepr.2023.100785_bib55","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jhep.2019.07.002","article-title":"News in pathophysiology, definition and classification of hepatorenal syndrome: a step beyond the International Club of Ascites (ICA) consensus document","volume":"71","author":"Angeli","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100785_bib56","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1053\/j.gastro.2008.02.024","article-title":"Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study","volume":"134","author":"Mart\u00edn-Llah\u00ed","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2023.100785_bib57","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1053\/j.gastro.2016.02.026","article-title":"Terlipressin plus albumin is more effective than albumin alone in improving renal function in patients with cirrhosis and hepatorenal syndrome type 1","volume":"150","author":"Boyer","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2023.100785_bib58","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa2008290","article-title":"Terlipressin plus albumin for the treatment of type 1 hepatorenal syndrome","volume":"384","author":"Wong","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhepr.2023.100785_bib59","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/hep.27709","article-title":"Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: a randomized trial","volume":"62","author":"Cavallin","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100785_bib60","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1053\/j.gastro.2008.02.014","article-title":"A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome","volume":"134","author":"Sanyal","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2023.100785_bib61","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/hep.28396","article-title":"Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: a randomized controlled study","volume":"63","author":"Cavallin","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100785_bib62","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s12664-018-0876-3","article-title":"Noradrenaline versus terlipressin in the management of type 1 hepatorenal syndrome: a randomized controlled study","volume":"37","author":"Saif","year":"2018","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100785_bib63","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1111\/j.1572-0241.2008.01828.x","article-title":"An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response","volume":"103","author":"Sharma","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100785_bib64","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1053\/jhep.2003.50276","article-title":"Octreotide in hepatorenal syndrome: a randomized, double-blind, placebo-controlled, crossover study","volume":"38","author":"Pomier-Layrargues","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100785_bib65","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jhep.2007.04.010","article-title":"Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study","volume":"47","author":"Alessandria","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100785_bib66","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/liv.12179","article-title":"Noradrenaline vs terlipressin in the treatment of type 2 hepatorenal syndrome: a randomized pilot study","volume":"33","author":"Ghosh","year":"2013","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2023.100785_bib67","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1053\/jhep.2002.35819","article-title":"Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study","volume":"36","author":"Ortega","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100785_bib68","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12876-015-0389-9","article-title":"Albumin treatment regimen for type 1 hepatorenal syndrome: a dose-response meta-analysis","volume":"15","author":"Salerno","year":"2015","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100785_bib69","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0140-6736(85)92147-6","article-title":"Paracentesis versus diuretics in the treatment of cirrhotics with tense ascites","volume":"1","author":"Quintero","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.jhepr.2023.100785_bib70","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/0016-5085(87)91007-9","article-title":"Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study","volume":"93","author":"Gin\u00e9s","year":"1987","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2023.100785_bib71","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1053\/gast.1997.v113.pm9247479","article-title":"Paracentesis-induced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis","volume":"113","author":"Ruiz-del-Arbol","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2023.100785_bib72","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/0016-5085(88)90691-9","article-title":"Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis","volume":"94","author":"Gin\u00e8s","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2023.100785_bib73","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0016-5085(96)70068-9","article-title":"Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis","volume":"111","author":"Gin\u00e8s","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2023.100785_bib74","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0168-8278(05)80070-4","article-title":"Total paracentesis with dextran 40 vs diuretics in the treatment of ascites in cirrhosis: a randomized controlled study","volume":"20","author":"Sol\u00e0","year":"1994","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100785_bib75","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/hep.24786","article-title":"Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials","volume":"55","author":"Bernardi","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100785_bib76","first-page":"CD004039","article-title":"Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesis","volume":"6","author":"Simonetti","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jhepr.2023.100785_bib77","doi-asserted-by":"crossref","first-page":"100547","DOI":"10.1016\/j.aohep.2021.100547","article-title":"Safety and efficacy of human serum albumin treatment in patients with cirrhotic ascites undergoing paracentesis: a systematic review and meta-analysis","volume":"26","author":"Shrestha","year":"2021","journal-title":"Ann Hepatol"},{"issue":"Suppl 6","key":"10.1016\/j.jhepr.2023.100785_bib78","first-page":"vi1","article-title":"Guidelines on the management of ascites in cirrhosis","volume":"55","author":"Moore","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2023.100785_bib79","first-page":"394","article-title":"Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites","volume":"92","author":"Peltekian","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100785_bib80","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/hep.31071","article-title":"Paracentesis-induced circulatory dysfunction with modest-volume paracentesis is partly ameliorated by albumin infusion in acute-on-chronic liver failure","volume":"72","author":"Arora","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100785_bib81","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1111\/j.1365-2036.2010.04473.x","article-title":"The rate of decompensation and clinical progression of disease in people with cirrhosis: a cohort study","volume":"32","author":"Fleming","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2023.100785_bib82","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jhep.2015.07.004","article-title":"Mechanisms of decompensation and organ failure in cirrhosis: from peripheral arterial vasodilation to systemic inflammation hypothesis","volume":"63","author":"Bernardi","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100785_bib83","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.1840080532","article-title":"Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis","volume":"8","author":"Schrier","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100785_bib84","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S0140-6736(62)90895-4","article-title":"The effect of repeated albumin infusions in patients with cirrhosis","volume":"2","author":"Wilkinson","year":"1962","journal-title":"Lancet"},{"key":"10.1016\/j.jhepr.2023.100785_bib85","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0168-8278(99)80194-9","article-title":"Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial","volume":"30","author":"Gentilini","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100785_bib86","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.3748\/wjg.v12.i9.1403","article-title":"Long-term albumin infusion improves survival in patients with cirrhosis and ascites: an unblinded randomized trial","volume":"12","author":"Romanelli","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100785_bib87","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/jgh.15253","article-title":"Long-term albumin administration in patients with cirrhosis and ascites: a meta-analysis of randomized controlled trials","volume":"36","author":"Sandi","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100785_bib88","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/liv.13968","article-title":"Long-term administration of human albumin improves survival in patients with cirrhosis and refractory ascites","volume":"39","author":"Di Pascoli","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2023.100785_bib89","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jhep.2020.08.021","article-title":"On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites","volume":"74","author":"Caraceni","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100785_bib90","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0168-8278(12)60002-6","article-title":"Management of bacterial infections in cirrhosis","volume":"56","author":"Fern\u00e1ndez","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100785_bib91","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/hep.25532","article-title":"Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study","volume":"55","author":"Fern\u00e1ndez","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100785_bib92","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/jhep.2002.30082","article-title":"Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis","volume":"35","author":"Fern\u00e1ndez","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100785_bib93","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1053\/j.gastro.2010.06.019","article-title":"Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis","volume":"139","author":"Arvaniti","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2023.100785_bib94","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jhep.2014.01.024","article-title":"Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013","volume":"60","author":"Jalan","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100785_bib95","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/hep.27941","article-title":"The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: results of a randomized, controlled clinical trial","volume":"63","author":"Piano","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100785_bib96","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/apt.13172","article-title":"Review article: spontaneous bacterial peritonitis--bacteriology, diagnosis, treatment, risk factors and prevention","volume":"41","author":"Dever","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2023.100785_bib97","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM199908053410603","article-title":"Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"341","author":"Sort","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhepr.2023.100785_bib98","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/00365520902719273","article-title":"Effect of intravenous albumin on endotoxin removal, cytokines, and nitric oxide production in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"44","author":"Chen","year":"2009","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100785_bib99","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/hep.20829","article-title":"A randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis","volume":"42","author":"Fern\u00e1ndez","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100785_bib100","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1053\/j.gastro.2005.09.024","article-title":"Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis: value of MELD score","volume":"129","author":"Terra","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2023.100785_bib101","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jhep.2012.06.013","article-title":"Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled study","volume":"57","author":"Guevara","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100785_bib102","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.jhep.2014.11.017","article-title":"Effect of albumin in cirrhotic patients with infection other than spontaneous bacterial peritonitis. A randomized trial","volume":"62","author":"Th\u00e9venot","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100785_bib103","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.cgh.2019.07.055","article-title":"Efficacy of albumin treatment for patients with cirrhosis and infections unrelated to spontaneous bacterial peritonitis","volume":"18","author":"Fern\u00e1ndez","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100785_bib104","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.gastro.2019.03.021","article-title":"Effects of albumin treatment on systemic and portal hemodynamics and systemic inflammation in patients with decompensated cirrhosis","volume":"157","author":"Fern\u00e1ndez","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2023.100785_bib105","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.dld.2020.05.047","article-title":"Efficacy and Safety of IV albumin for non-spontaneous bacterial peritonitis infection among patients with cirrhosis: a systematic review and meta-analysis","volume":"52","author":"Wong","year":"2020","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhepr.2023.100785_bib106","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1056\/NEJMra1600561","article-title":"Hepatic encephalopathy","volume":"375","author":"Wijdicks","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhepr.2023.100785_bib107","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.jhep.2022.06.001","article-title":"EASL Clinical Practice Guidelines on the management of hepatic encephalopathy","volume":"77","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100785_bib108","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jhep.2014.05.042","article-title":"European association for the study of the liver. Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the European association for the study of the liver and the American association for the study of liver diseases","volume":"61","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100785_bib109","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.nurt.2010.05.015","article-title":"Astrocyte glutamine synthetase: importance in hyperammonemic syndromes and potential target for therapy","volume":"7","author":"Brusilow","year":"2010","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jhepr.2023.100785_bib110","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/jnc.12119","article-title":"Hyperammonemia alters the modulation by different neurosteroids of the glutamate-nitric oxide-cyclic GMP pathway through NMDA- GABAA - or sigma receptors in cerebellum in vivo","volume":"125","author":"Gonz\u00e1lez-Usano","year":"2013","journal-title":"J Neurochem"},{"key":"10.1016\/j.jhepr.2023.100785_bib111","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/hep.28598","article-title":"Nonabsorbable disaccharides for hepatic encephalopathy: a systematic review and meta-analysis","volume":"64","author":"Gluud","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100785_bib112","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa0907893","article-title":"Rifaximin treatment in hepatic encephalopathy","volume":"362","author":"Bass","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhepr.2023.100785_bib113","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/hep.510250609","article-title":"Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study","volume":"25","author":"Kircheis","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100785_bib114","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11011-012-9351-5","article-title":"Oxidative stress: a systemic factor implicated in the pathogenesis of hepatic encephalopathy","volume":"28","author":"Bosoi","year":"2013","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.jhepr.2023.100785_bib115","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.dld.2012.07.002","article-title":"Serum endotoxin and inflammatory mediators in patients with cirrhosis and hepatic encephalopathy","volume":"44","author":"Jain","year":"2012","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhepr.2023.100785_bib116","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.jhep.2013.07.020","article-title":"Effects of intravenous albumin in patients with cirrhosis and episodic hepatic encephalopathy: a randomized double-blind study","volume":"59","author":"Sim\u00f3n-Talero","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100785_bib117","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1111\/jgh.13666","article-title":"Randomized controlled trial comparing lactulose plus albumin versus lactulose alone for treatment of hepatic encephalopathy","volume":"32","author":"Sharma","year":"2017","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100785_bib118","doi-asserted-by":"crossref","first-page":"8502","DOI":"10.18632\/aging.102335","article-title":"Albumin infusion may decrease the incidence and severity of overt hepatic encephalopathy in liver cirrhosis","volume":"11","author":"Bai","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.jhepr.2023.100785_bib119","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jhep.2022.09.009","article-title":"A double-blind randomized placebo-controlled trial of albumin in patients with hepatic encephalopathy: HEAL study","volume":"78","author":"Fagan","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100785_bib120","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.dld.2021.04.030","article-title":"Efficacy and safety of albumin infusion for overt hepatic encephalopathy: a systematic review and meta-analysis","volume":"53","author":"Teh","year":"2021","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhepr.2023.100785_bib121","article-title":"Albumin in the management of hepatic encephalopathy: a systematic review and meta-analysis","volume":"26","author":"Is","year":"2021","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jhepr.2023.100785_bib122","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1007\/s11011-022-01002-8","article-title":"Albumin therapy for hepatic encephalopathy: current evidence and controversies","volume":"38","author":"Wong","year":"2023","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.jhepr.2023.100785_bib123","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/hep.21412","article-title":"Hyponatremia in cirrhosis: results of a patient population survey","volume":"44","author":"Angeli","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100785_bib124","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/cld.790","article-title":"Approach to hyponatremia in cirrhosis","volume":"13","author":"Attar","year":"2019","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"10.1016\/j.jhepr.2023.100785_bib125","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMoa0801209","article-title":"Hyponatremia and mortality among patients on the liver-transplant waiting list","volume":"359","author":"Kim","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhepr.2023.100785_bib126","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1590-8658(00)80844-0","article-title":"Clinical relevance of hyponatraemia for the hospital outcome of cirrhotic patients","volume":"32","author":"Borroni","year":"2000","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhepr.2023.100785_bib127","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.14309\/ajg.0000000000000786","article-title":"Hyponatremia in cirrhosis: an update","volume":"115","author":"Alukal","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100785_bib128","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/s41395-018-0119-3","article-title":"The impact of albumin use on resolution of hyponatremia in hospitalized patients with cirrhosis","volume":"113","author":"Bajaj","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100785_bib129","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.14309\/ajg.0000000000001488","article-title":"Targeted albumin therapy does not improve short-term outcome in hyponatremic patients hospitalized with complications of cirrhosis: data from the ATTIRE trial","volume":"116","author":"China","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100785_bib130","doi-asserted-by":"crossref","first-page":"168","DOI":"10.14309\/ajg.0000000000001995","article-title":"Correction and prevention of hyponatremia in patients with cirrhosis and ascites - post hoc analysis of the ANSWER study database","volume":"118","author":"Zaccherini","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100785_bib131","doi-asserted-by":"crossref","first-page":"5928","DOI":"10.3390\/jcm11195928","article-title":"Use of human albumin administration for the prevention and treatment of hyponatremia in patients with liver cirrhosis: a systematic review and meta-analysis","volume":"11","author":"Bai","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.jhepr.2023.100785_bib132","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/hep.32378","article-title":"AASLD Practice Guidance: palliative care and symptom-based management in decompensated cirrhosis","volume":"76","author":"Rogal","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100785_bib133","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/hep.510230211","article-title":"Cirrhosis and muscle cramps: evidence of a causal relationship","volume":"23","author":"Angeli","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100785_bib134","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1097\/MEG.0000000000000714","article-title":"Randomized placebo-controlled study of baclofen in the treatment of muscle cramps in patients with liver cirrhosis","volume":"28","author":"Elfert","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100785_bib135","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/0168-8278(91)90944-7","article-title":"A randomized controlled trial of quinidine in the treatment of cirrhotic patients with muscle cramps","volume":"12","author":"Lee","year":"1991","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100785_bib136","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1378\/chest.124.3.1016","article-title":"Cirrhosis as a risk factor for sepsis and death: analysis of the National Hospital Discharge Survey","volume":"124","author":"Foreman","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.jhepr.2023.100785_bib137","doi-asserted-by":"crossref","first-page":"i1585","DOI":"10.1136\/bmj.i1585","article-title":"Sepsis: pathophysiology and clinical management","volume":"353","author":"Gotts","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jhepr.2023.100785_bib138","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1002\/hep.23264","article-title":"Severe sepsis in cirrhosis","volume":"50","author":"Gustot","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100785_bib139","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1478-3231.2003.00870.x","article-title":"Coagulation disorders in patients with cirrhosis and severe sepsis","volume":"23","author":"Plessier","year":"2003","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2023.100785_bib140","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/hep.30412","article-title":"Management of sepsis in patients with cirrhosis: current evidence and practical approach","volume":"70","author":"Simonetto","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100785_bib141","doi-asserted-by":"crossref","first-page":"R78","DOI":"10.1186\/cc12687","article-title":"Increased survival of cirrhotic patients with septic shock","volume":"17","author":"Sauneuf","year":"2013","journal-title":"Crit Care"},{"key":"10.1016\/j.jhepr.2023.100785_bib142","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s12072-021-10164-z","article-title":"Comparison of 5% human albumin and normal saline for fluid resuscitation in sepsis induced hypotension among patients with cirrhosis (FRISC study): a randomized controlled trial","volume":"15","author":"Philips","year":"2021","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhepr.2023.100785_bib143","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jhep.2022.03.043","article-title":"A randomized-controlled trial comparing 20% albumin to plasmalyte in patients with cirrhosis and sepsis-induced hypotension [ALPS trial]","volume":"77","author":"Maiwall","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100785_bib144","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/liv.13375","article-title":"Changes in cardiac output and incidence of volume overload in cirrhotics receiving 20% albumin infusion","volume":"37","author":"Shasthry","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2023.100785_bib145","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-230X-8-39","article-title":"Haemodynamic effects of plasma-expansion with hyperoncotic albumin in cirrhotic patients with renal failure: a prospective interventional study","volume":"8","author":"Umgelter","year":"2008","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100785_bib146","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.21037\/atm-21-2136","article-title":"Human albumin infusion strategy in liver cirrhosis: liberal or restrictive?","volume":"9","author":"Bai","year":"2021","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.jhepr.2023.100785_bib147","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1111\/liv.15367","article-title":"Respiratory events with terlipressin and albumin in hepatorenal syndrome: a review and clinical guidance","volume":"42","author":"Allegretti","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2023.100785_bib148","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s00540-007-0512-3","article-title":"Anaphylactoid shock in a patient following 5% human serum albumin infusion during off-pump coronary artery bypass grafting","volume":"21","author":"Fujita","year":"2007","journal-title":"J Anesth"},{"key":"10.1016\/j.jhepr.2023.100785_bib149","doi-asserted-by":"crossref","first-page":"51","DOI":"10.18176\/jiaci.0325","article-title":"Human serum albumin induced anaphylaxis in a patient with good tolerance to human plasma","volume":"29","author":"Moreno Lozano","year":"2019","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jhepr.2023.100785_bib150","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2222.1979.tb01527.x","article-title":"Anaphylactoid reactions to infusions of plasma protein and human serum albumin. Role of aggregated proteins and of stabilizers added during production","volume":"9","author":"Ring","year":"1979","journal-title":"Clin Allergy"},{"key":"10.1016\/j.jhepr.2023.100785_bib151","first-page":"85","article-title":"Anaphylaxis to human serum albumin","volume":"61","author":"Stafford","year":"1988","journal-title":"Ann Allergy"},{"key":"10.1016\/j.jhepr.2023.100785_bib152","first-page":"160","article-title":"Chemical and immunochemical characterization of polymers of aggregates in preparations of human serum albumin","volume":"16","author":"Dengler","year":"1989","journal-title":"Infusionstherapie"},{"key":"10.1016\/j.jhepr.2023.100785_bib153","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1423-0410.1994.tb01646.x","article-title":"Identification and removal of polymer- and aggregate-forming proteins in human plasma albumin preparations","volume":"67","author":"Jensen","year":"1994","journal-title":"Vox Sang"},{"key":"10.1016\/j.jhepr.2023.100785_bib154","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1172\/JCI102108","article-title":"An evaluation of human serum albumin in the treatment of cirrhosis of the liver","volume":"28","author":"Faloon","year":"1949","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhepr.2023.100785_bib155","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1172\/JCI101959","article-title":"The use of concentrated human serum albumin in the treatment of cirrhosis of the liver","volume":"27","author":"Kunkel","year":"1948","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhepr.2023.100785_bib156","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12876-020-01337-5","article-title":"The impact of albumin infusion on the risk of rebleeding and in-hospital mortality in cirrhotic patients admitted for acute gastrointestinal bleeding: a retrospective study of a single institute","volume":"20","author":"Wang","year":"2020","journal-title":"BMC Gastroenterol"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555923001167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555923001167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:33:22Z","timestamp":1762900402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555923001167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":156,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S2589555923001167"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2023.100785","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of albumin infusion for cirrhosis-related complications: An international position statement","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2023.100785","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"100785"}}